Showing results (181-190 of 273) with videos related to
Sort By:
Pageof 28
Seminars in Urologic Oncology|July 2, 1998
Dose intensity: its limitation and the M. D. Anderson Cancer Center's view of its applicationR J AmatoSeminars in Urologic Oncology|May 17, 2001
Laparoscopic radical nephrectomyA Zisman, A J Pantuck, A S Belldegrun, et al.Seminars in Urologic Oncology|May 17, 2001
Biology of renal cell carcinoma: changing concepts in classification and stagingA J Pantuck, A Zisman, A BelldegrunSeminars in Urologic Oncology|May 1, 1996
Staging and prognosis of T3b bladder cancerD A Levy, H B GrossmanSeminars in Urologic Oncology|May 1, 1996
Characteristics of invasive bladder cancers: histological and molecular markersM Liebert, J SeigneSeminars in Urologic Oncology|May 1, 1996
Radiotherapy for stage T3b transitional cell carcinoma of the bladderA Pollack, G Z ZagarsSeminars in Urologic Oncology|May 1, 1996
What to do if the lymph nodes are positiveC P Evans, D A SwansonSeminars in Urologic Oncology|May 1, 1996
Optimal duration of neoadjuvant androgen withdrawal therapy before radical prostatectomy in clinically confined prostate cancerM E Gleave, S L Goldenberg, E C Jones, et al.Seminars in Urologic Oncology|May 1, 1996
Neoadjuvant hormonal treatment before radical prostatectomyR B Watson, M S SolowaySeminars in Urologic Oncology|February 1, 1996
Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological GroupW P Witjes, J A Witjes, G O Oosterhof, et al.Pageof 28